Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer
To explore the efficacy and safety of selective coverage radiotherapy in poorly differentiated and anaplastic thyroid cancer
Trial Details
- NCT ID
- NCT07777536
- Phase
- PHASE2
- Sponsor
- Fudan University
- Status
- RECRUITING
- Cancer Type
- Thyroid Cancer
- Interventions
- Selective coverage radiotherapy
- comprehensive coverage radiotherapy
- Locations (sample)
- Shanghai, Shanghai Municipality, China|31.22222,121.45806
Key Eligibility Criteria
- Age ≥ 18 years old
- Pathologically confirmed as ATC, thyroid cancer containing ATC components, PDTC (in accordance with Turin criteria), or other thyroid cancers with …
- Evaluated by the MDT and proposed to receive external beam radiotherapy, including postoperative R0/R1, R2 gross residual, inoperable local lesion,…
- ECOG performance status 0-2
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Thyroid Cancer Trials on Trialify →